YCM
Yiheng Capital Management’s Denali Therapeutics DNLI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.58M | Hold |
469,981
| – | – | 0.59% | 11 |
|
|
2025
Q1 | $6.39M | Sell |
469,981
-230,117
| -33% | -$3.13M | 0.59% | 11 |
|
|
2024
Q4 | $14.3M | Buy |
700,098
+100,000
| +17% | +$2.04M | 0.55% | 11 |
|
|
2024
Q3 | $17.5M | Sell |
600,098
-550,586
| -48% | -$16M | 0.9% | 11 |
|
|
2024
Q2 | $26.7M | Hold |
1,150,684
| – | – | 2.15% | 9 |
|
|
2024
Q1 | $23.6M | Hold |
1,150,684
| – | – | 1.31% | 10 |
|
|
2023
Q4 | $24.7M | Hold |
1,150,684
| – | – | 1.42% | 10 |
|
|
2023
Q3 | $23.7M | Hold |
1,150,684
| – | – | 1.21% | 13 |
|
|
2023
Q2 | $34M | Buy |
1,150,684
+136,000
| +13% | +$4.01M | 1.84% | 13 |
|
|
2023
Q1 | $23.4M | Hold |
1,014,684
| – | – | 0.92% | 16 |
|
|
2022
Q4 | $28.2M | Hold |
1,014,684
| – | – | 1.25% | 13 |
|
|
2022
Q3 | $31.1M | Hold |
1,014,684
| – | – | 1.92% | 12 |
|
|
2022
Q2 | $29.9M | Hold |
1,014,684
| – | – | 1.71% | 16 |
|
|
2022
Q1 | $32.6M | Buy |
1,014,684
+679,500
| +203% | +$21.9M | 1.49% | 17 |
|
|
2021
Q4 | $14.9M | Buy |
+335,184
| New | +$14.9M | 0.76% | 23 |
|